ZA944039B - Superoxide dismutase-4 - Google Patents

Superoxide dismutase-4

Info

Publication number
ZA944039B
ZA944039B ZA944039A ZA944039A ZA944039B ZA 944039 B ZA944039 B ZA 944039B ZA 944039 A ZA944039 A ZA 944039A ZA 944039 A ZA944039 A ZA 944039A ZA 944039 B ZA944039 B ZA 944039B
Authority
ZA
South Africa
Prior art keywords
polypeptide
sod
superoxide dismutase
polypeptides
nucleic acid
Prior art date
Application number
ZA944039A
Other languages
English (en)
Inventor
Craig A Rosen
Guo-Liang Yu
Claire M Fraser
Jeannine D Gocayne
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of ZA944039B publication Critical patent/ZA944039B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA944039A 1994-04-11 1994-06-08 Superoxide dismutase-4 ZA944039B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/225,757 US5506133A (en) 1994-04-11 1994-04-11 Superoxide dismutase-4

Publications (1)

Publication Number Publication Date
ZA944039B true ZA944039B (en) 1995-12-08

Family

ID=22846108

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944039A ZA944039B (en) 1994-04-11 1994-06-08 Superoxide dismutase-4

Country Status (13)

Country Link
US (3) US5506133A (fr)
EP (2) EP1158046A1 (fr)
JP (2) JPH09511648A (fr)
CN (2) CN1073154C (fr)
AT (1) ATE215599T1 (fr)
AU (1) AU683286B2 (fr)
CA (1) CA2187635A1 (fr)
DE (1) DE69430326T2 (fr)
DK (1) DK0775199T3 (fr)
ES (1) ES2173919T3 (fr)
PT (1) PT775199E (fr)
WO (1) WO1995027781A1 (fr)
ZA (1) ZA944039B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672509A (en) * 1993-08-25 1997-09-30 Pfizer Inc. hPDE IV-C: a human phosphodiesterase IV isozyme
US5506133A (en) * 1994-04-11 1996-04-09 Human Genome Sciences, Inc. Superoxide dismutase-4
US20060223077A1 (en) * 1997-06-06 2006-10-05 Human Genome Sciences, Inc. 207 human secreted proteins
FR2792000B1 (fr) * 1999-04-08 2003-04-11 Centre Nat Rech Scient Procede de cartographie d'une molecule d'adn comprenant une etape d'amplification ad infinitum
US20080125382A1 (en) * 2004-01-20 2008-05-29 Regents Of The University Of California Extracellular superoxide dismutase (EC-SOD) gene delivery to prevent oxidative injury
DE102007010785A1 (de) * 2007-03-02 2008-09-04 Henkel Ag & Co. Kgaa Verwendung von Superoxid-Dismutasen in Wasch- und Reinigungsmitteln
KR102593542B1 (ko) * 2021-06-10 2023-10-26 씨제이제일제당 주식회사 슈퍼옥사이드 디스뮤테이즈 1 변이체 및 이를 이용한 글루타치온 또는 그 유도체의 생산방법
CN116103253B (zh) * 2023-01-10 2026-04-28 杭州浦泰生物科技有限公司 一种重组人超氧化物歧化酶及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252476A (en) * 1983-10-03 1993-10-12 Chiron Corporation Superoxide dismutase cloning and expression in microorganisms
US5162217A (en) * 1984-08-27 1992-11-10 Bio-Technology General Corp. Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof
US5242794A (en) * 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US5248603A (en) * 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase
JPS62103026A (ja) * 1985-10-28 1987-05-13 Nikken Food Kk Ｓｏｄ活性剤およびその製造法
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
ES2083357T3 (es) * 1987-03-14 1996-04-16 Boehringer Ingelheim Int Manganeso-superoxido-dismutasa humana (hmn-sod).
JPS63313581A (ja) * 1987-06-16 1988-12-21 Ube Ind Ltd 修飾ス−パ−オキシドジスムタ−ゼ
JPH02156884A (ja) * 1988-12-10 1990-06-15 Hagiwara Yoshihide ポリペプチド及びその製造方法
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5360729A (en) * 1989-11-07 1994-11-01 Bio-Technology General Corp. Method for purification of recombinant copper/zinc (CU-ZN) superoxide dismutase from bacteria or eucaryotic cells
IL96136A (en) * 1989-11-07 2000-12-06 Bio Technology General Corp Use of hydrophobic chromatography in a method for purification of copper-zinc superoxide dismutase from cells containing same
US5219737A (en) 1990-03-27 1993-06-15 Kikkoman Corporation Mutant luciferase of a firefly, mutant luciferase genes, recombinant dnas containing the genes and a method of producing mutant luciferase
JPH04108379A (ja) * 1990-08-28 1992-04-09 Suntory Ltd 新規スーパーオキサイドディスムターゼ
AU8947791A (en) * 1990-11-01 1992-05-26 Scripps Research Institute, The Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
JPH04248984A (ja) * 1991-02-05 1992-09-04 Kuraray Co Ltd スーパーオキシドジスムターゼ誘導体およびその製造方法
JPH04312533A (ja) * 1991-04-09 1992-11-04 Nippon Kayaku Co Ltd 脳虚血症治療剤
JPH04327541A (ja) * 1991-04-23 1992-11-17 Nippon Kayaku Co Ltd 拒絶反応による移植臓器障害治療剤
US5506133A (en) * 1994-04-11 1996-04-09 Human Genome Sciences, Inc. Superoxide dismutase-4

Also Published As

Publication number Publication date
ES2173919T3 (es) 2002-11-01
EP0775199A1 (fr) 1997-05-28
DK0775199T3 (da) 2002-06-03
US20020081288A1 (en) 2002-06-27
CN1152337A (zh) 1997-06-18
CN1332240A (zh) 2002-01-23
CN1073154C (zh) 2001-10-17
DE69430326D1 (de) 2002-05-08
EP0775199B1 (fr) 2002-04-03
EP0775199A4 (fr) 1997-12-03
EP1158046A1 (fr) 2001-11-28
JP2002085082A (ja) 2002-03-26
CA2187635A1 (fr) 1995-10-19
ATE215599T1 (de) 2002-04-15
AU7312394A (en) 1995-10-30
US5506133A (en) 1996-04-09
US6635252B2 (en) 2003-10-21
AU683286B2 (en) 1997-11-06
JPH09511648A (ja) 1997-11-25
US5871729A (en) 1999-02-16
PT775199E (pt) 2002-08-30
DE69430326T2 (de) 2002-11-07
WO1995027781A1 (fr) 1995-10-19

Similar Documents

Publication Publication Date Title
ZA943465B (en) Transforming growth factor alpha H1
ATE277078T1 (de) N-terminal modifizierte polypeptide, und herstellungsprozess
EP0233838A3 (fr) Facteur stimulant les neurites, et procédé de préparation
PT85285A (en) Process for producing il-6 and of pharmaceutical compositions containing the same
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
WO2001045746A3 (fr) Methodes et compositions permettant de prolonger les demi-vies d'elimination de composes bioactifs
MX26714A (es) Procedimiento para la preparacion de albumina de SUERO HUMANO VECTOR Y PLASMIDO USADOS ASI COMO LEVADURA METILOTROFICA TRANSFORMADA OBTENIDA
DK1029870T3 (da) Hybride immunglobuliner til anvendelse i terapeutiske fremgangsmåder
GB8709871D0 (en) Peptides
HUP0103758A2 (hu) Neurotróf faktorok
PT85849A (en) Process for the preparation of novel lymphokine related peptides
EP0355572A3 (en) Peptide derivatives, their production and use
DK1396542T3 (da) P-selectin ligand protein
DE3783257D1 (de) Peptid, dessen verfahren zur herstellung, sie enthaltende pharmazeutische zusammensetzung und benutzung.
CA2075974A1 (fr) Reactifs d'affinite entierement synthetiques
ATE215599T1 (de) Superoxid dismutase-4
HU886264D0 (en) Process for purification of proteins
CA2128215A1 (fr) L'autotaxine, proteine stimulant la motilite qui est utile dans le diagnostic et le traitement du cancer
DE3467340D1 (en) Process for purification of 1,2-unsaturated carboxylic acids and/or esters thereof
EP0199072A3 (en) Process for the preparation of 2,2,2 trifluoroethanol
NO983579L (no) FremgangsmÕte for produksjon av rDSPA <alfa>1
ATE133421T1 (de) Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form
IT1260603B (it) Procedimento per preparare una soluzione contentente semitrichinoyl, con proprieta' terapeutiche.
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도